4.59MMarket Cap-306P/E (TTM)
1.1400High1.1200Low6.57KVolume1.1200Open1.1100Pre Close7.40KTurnover0.17%Turnover RatioLossP/E (Static)4.10MShares5.939952wk High1.13P/B4.31MFloat Cap0.894052wk Low--Dividend TTM3.84MShs Float1910.0000Historical High--Div YieldTTM1.80%Amplitude0.8940Historical Low1.1260Avg Price1Lot Size
Predictive Oncology Stock Forum
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
Predictive Oncology (NASDAQ: POAI) has launched a unique 3D cell culture model to enhance cancer drug discovery and future drug development. These organ-specific in vitro models better mimic human tissue compared to traditional 2D assays, allowing for more accurate clinical outcome predictions and optimized candidate selection for clinical trials.
The global 3D...
Predictive Oncology Inc. (NASDAQ: POAI), a company in AI-driven drug discovery and biologics, has announced significant positive results from a retrospective study conducted in collaboration with UPMC Magee-Womens Hospital. These results are set to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Me...
No comment yet